Vertex Pharmaceuticals, Inc. (VRTX)
449.53
-5.14
(-1.13%)
USD |
NASDAQ |
Jan 14, 16:00
449.50
-0.03
(-0.01%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap: 114.05B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 145.44B |
| Amgen, Inc. | 177.14B |
| Eli Lilly & Co. | 960.61B |
| Merck & Co., Inc. | 275.53B |
| Regeneron Pharmaceuticals, Inc. | 79.26B |
Market Cap Related Metrics
| PE Ratio | 31.68 |
| PS Ratio | 9.926 |
| Price to Book Value | 6.586 |
| Price to Free Cash Flow | 34.90 |
| Price | 449.53 |
| Earnings Yield | 3.16% |
| Operating PE Ratio | 25.72 |
| Normalized PE Ratio | 28.73 |